Baader Bank Aktiengesellschaft Has $4.63 Million Holdings in Teleflex Incorporated $TFX

Baader Bank Aktiengesellschaft cut its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 10.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,768 shares of the medical technology company’s stock after selling 4,565 shares during the period. Baader Bank Aktiengesellschaft owned about 0.09% of Teleflex worth $4,634,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Heartland Advisors Inc. raised its stake in shares of Teleflex by 107.8% in the first quarter. Heartland Advisors Inc. now owns 215,998 shares of the medical technology company’s stock worth $25,836,000 after acquiring an additional 112,071 shares during the last quarter. Bessemer Group Inc. boosted its holdings in Teleflex by 30.5% in the first quarter. Bessemer Group Inc. now owns 47,798 shares of the medical technology company’s stock valued at $5,718,000 after acquiring an additional 11,180 shares during the last quarter. Illinois Municipal Retirement Fund grew its holdings in Teleflex by 17.1% during the 1st quarter. Illinois Municipal Retirement Fund now owns 24,596 shares of the medical technology company’s stock worth $2,942,000 after acquiring an additional 3,591 shares during the period. Principal Financial Group Inc. raised its position in shares of Teleflex by 2.0% during the 1st quarter. Principal Financial Group Inc. now owns 214,193 shares of the medical technology company’s stock valued at $25,620,000 after acquiring an additional 4,214 shares during the last quarter. Finally, Fifth Third Bancorp lifted its stake in shares of Teleflex by 3,204.8% in the 1st quarter. Fifth Third Bancorp now owns 68,144 shares of the medical technology company’s stock valued at $8,151,000 after purchasing an additional 66,082 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Mizuho lifted their price objective on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $140.00 to $160.00 in a research report on Monday, June 8th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Finally, Wells Fargo & Company increased their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $148.00.

Teleflex Trading Down 0.2%

NYSE:TFX opened at $134.33 on Tuesday. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The stock has a market capitalization of $5.95 billion, a PE ratio of -5.89, a price-to-earnings-growth ratio of 1.00 and a beta of 0.82. The business’s 50-day simple moving average is $130.57 and its 200-day simple moving average is $120.56.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The business had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.Teleflex’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts expect that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio is currently -5.96%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.